Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-01FDA Approved: QUINAPRIL — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for quinapril filed by Solco Healthcare US, LLC under ANDA205823.
-
FDA approval · 2019-11-01FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of spironolactone and hydrochlorothiazide from Sun Pharmace…
-
FDA approval · 2019-10-30FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate by Hospira, Inc. under ANDA 078085, finalizing changes to the generic produc…
-
FDA approval · 2019-10-24FDA Approved: METOPROLOL — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved Baxter Healthcare Corporation's supplemental application for Metoprolol Tartrate under ANDA 078950. This approval updates a…
-
FDA approval · 2019-10-24FDA Approved: AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s supplemental application for a combination tablet of amlodipine besylate and olmesartan medoxomil …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-10-24FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for the generic combination drug Amlodipine and Olmesartan Medoxomil, manufactured by Macleods Pharm…
-
CLINICAL_TRIALS research · 2019-10-22Clinical Trial Update: Diaphragmatic Breathing and Heart Rate Variability Training for Improving Hypertension in Fragile X Associated Tremor/Ataxia [Phase 3]
A Phase 3 clinical trial evaluating diaphragmatic breathing and heart rate variability training to improve hypertension in FXTAS (Fragile X-…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Electronic Health Record-Based Clinical Decision Support to Improve Blood Pressure Management in Adolescents [NA]
Clinical trial evaluating electronic health record–based decision support to improve blood pressure management in adolescents has completed …
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives [Phase 3]
Phase 3 trial evaluating the effects of celecoxib on blood pressure in hypertensive patients already on antihypertensives has completed with…
-
FDA approval · 2019-10-17FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approves a supplemental application for Benicar (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Stand & Move at Work [NA]
Completed clinical trial results for a study on standing and movement at work addressing obesity and hypertension (and diabetes mentioned in…
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up
A completed long-term clinical trial investigated how insulin sensitivity relates to cardiovascular risk markers over 10–20 years of follow-…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: The Health Access and Recovery Peer Program [NA]
Clinical trial update for the Health Access and Recovery Peer Program; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment [Phase 2]
Phase 2 exploratory study of CS-3150 in Japanese hypertensive patients with moderate renal impairment has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Efficacy and Safety of Ambrisentan in Children 8-18yrs [Phase 2]
Phase 2 trial update on ambrisentan in children aged 8-18 assessing efficacy and safety; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE) [NA]
Clinical trial update for renal denervation using the Vessix system in hypertension (REDUCE HTN:REINFORCE) completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study [Phase 4]
Phase 4 clinical trial investigating paracetamol treatment for effects on blood pressure in hypertension patients has completed.
-
FDA approval · 2019-10-01FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
The FDA approved a supplemental application for Verapamil Hydrochloride by Teva Pharmaceuticals Inc., updating the drug’s labeling and appro…
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: The SCCS Polypill Pilot Trial [Phase 2]
Phase 2 pilot trial update for the SCCS Polypill addressing hypertension and hyperlipidemia; trial completed with results posted.
-
FDA approval · 2019-09-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Verapamil Hydrochloride from Glenmark Pharmaceuticals, updating an already approved generic …
-
FDA approval · 2019-09-26FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for lisinopril filed by Solco Healthcare U.S., LLC under an ANDA. The action authorizes changes …
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: Tailored Approaches to Improve Medication Adherence [NA]
Completed clinical trial focusing on tailored approaches to improve medication adherence in hypertension; results posted in 2019.
-
FDA approval · 2019-09-25FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for verapamil hydrochloride (generic) from Nivagen Pharmaceuticals, Inc., authorizing the sale o…
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)
A completed clinical trial assessing the impact of calcium channel blockers on cognitive function in very elderly individuals; results poste…
-
FDA approval · 2019-09-20FDA Approved: VALSARTAN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves a supplemental application for VALSARTAN by Amneal Pharmaceuticals LLC (ANDA 204011) to support the generic product.